Real-world incidence and outcomes of immune-related adverse events in NSCLC patients

被引：1
|
作者：
Knox, A. [1 ]
Cloney, T. [1 ]
Janssen, H. [1 ]
Solomon, B. [1 ]
Alexander, M. [2 ]
John, T. [1 ]
机构：
[1] Peter MacCallum Canc Ctr, Med Oncol, Melbourne, Vic, Australia
[2] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic, Australia
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.10.629
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
551P
引用
收藏
页码：S1684 / S1684
页数：1
相关论文
共 50 条
  • [1] Defining real-world criteria for immune-related adverse events (irAEs).
    Singh, Prabhsimranjot
    Brito, Amanda
    Abdulnour, Raja-Elie E.
    Grover, Shilpa
    Yenulevich, Eric
    Stuver, Sherri Oliver
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [2] Real-world management of immune-related adverse events in the community setting
    Johnson, D. B.
    Bruno, D.
    Rioth, M.
    Zhang, C.
    Palaia, J.
    Pisupati, R.
    Bond, C.
    Rosenblatt, L. C.
    Broome, R. G.
    Teka, M.
    Kluger, H.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1268 - S1269
  • [3] Real-world characterization of patients with cancer admitted with immune-related adverse events (irAEs).
    Eng, Lawson
    Chen, RuiQui
    Smith, Elliot Charles
    Chan, Sze Wah Samuel
    Hueniken, Katrina
    Brown, M. Catherine
    Majeed, Habeeb
    Ross, Kendra
    Gray, Diana
    Xu, Wei
    Hogg, David
    Sridhar, Srikala S.
    Sacher, Adrian G.
    Leighl, Natasha B.
    Krzyzanowska, Monika K.
    Liu, Geoffrey
    Butler, Marcus O.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08)
  • [4] Acknowledging and addressing real-world challenges to treating immune-related adverse events
    von Itzstein, Mitchell S.
    Gerber, David E.
    Bermas, Bonnie L.
    Meara, Alexa
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (07)
  • [5] Real-World Adherence to Toxicity Management Guidelines for Immune-Related Adverse Events
    Teimouri, Arezou
    Minard, Laura, V
    Scott, Samantha N.
    Daniels, Amanda
    Snow, Stephanie
    CURRENT ONCOLOGY, 2022, 29 (05) : 3104 - 3117
  • [6] Real-World Clinical and Economic Outcomes in Selected Immune-Related Adverse Events Among Patients with Cancer Receiving Immune Checkpoint Inhibitors
    Zheng, Ying
    Kim, Ruth
    Yu, Ting
    Gayle, Julie A.
    Wassel, Christina L.
    Dreyfus, Jill
    Phatak, Hemant
    George, Saby
    ONCOLOGIST, 2021, 26 (11): : E2002 - E2012
  • [7] IMMUNE-RELATED ADVERSE EVENTS FROM IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH HEPATOCELLULAR CARCINOMA: A REAL-WORLD EXPERIENCE
    Gampa, Anuhya
    Peeraphatdit, Thoetchai
    Charlton, Michael R.
    Pillai, Anjana A.
    HEPATOLOGY, 2020, 72 : 694A - 695A
  • [8] Immune-Related Adverse Events with Durvalumab Consolidation in a Real-World Cohort of Patients with Non-Small Cell Lung Cancer (NSCLC)
    Montenegro, G. Bravo
    Serzan, M.
    Belouali, A.
    Sackstein, P.
    Chen, K.
    Rao, S.
    Veytsman, I.
    Madhavan, S.
    Liu, S.
    Kim, C.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S366 - S366
  • [9] Immune-related Adverse Events of Pembrolizumab in a Large Real-world Cohort of Patients With NSCLC With a PD-L1 Expression ≥ 50% and Their Relationship With Clinical Outcomes
    Cortellini, Alessio
    Friedlaender, Alex
    Banna, Giuseppe L.
    Porzio, Giampiero
    Bersanelli, Melissa
    Cappuzzo, Federico
    Aerts, Joachim G. J., V
    Giusti, Raffaele
    Bria, Emilio
    Cortinovis, Diego
    Grossi, Francesco
    Migliorino, Maria R.
    Galetta, Domenico
    Passiglia, Francesco
    Berardi, Rossana
    Mazzoni, Francesca
    Di Noia, Vincenzo
    Signorelli, Diego
    Tuzi, Alessandro
    Gelibter, Alain
    Marchetti, Paolo
    Macerelli, Marianna
    Rastelli, Francesca
    Chiari, Rita
    Rocco, Danilo
    Inno, Alessandro
    Di Marino, Pietro
    Mansueto, Giovanni
    Zoratto, Federica
    Santoni, Matteo
    Tudini, Marianna
    Ghidini, Michele
    Filetti, Marco
    Catino, Annamaria
    Pizzutilo, Pamela
    Sala, Luca
    Occhipinti, Mario Alberto
    Citarella, Fabrizio
    Marco, Russano
    Torniai, Mariangela
    Cantini, Luca
    Follador, Alessandro
    Sforza, Vincenzo
    Nigro, Olga
    Ferrara, Miriam G.
    D'Argento, Ettore
    Leonetti, Alessandro
    Pettoruti, Linda
    Antonuzzo, Lorenzo
    Scodes, Simona
    CLINICAL LUNG CANCER, 2020, 21 (06) : 498 - +
  • [10] Pharmacist's role in immune-related adverse events management: real-world incidence and risk evaluation from immunotherapy
    Meanwatthana, J.
    Chantarasap, P.
    Chuatrisorn, I
    Wiriya, T.
    Jitawatanarat, P.
    INTERNATIONAL JOURNAL OF PHARMACY PRACTICE, 2022, 30 (04) : 377 - 382
12345